JB Chemicals & Pharmaceuticals on Friday said its profit after tax (PAT) increased 43 per cent to Rs 126 crore in the March quarter, driven by strong sales. The drug maker had reported a PAT of Rs 88 crore in the March quarter of FY23.
Subscribe To Our Free Newsletter |